Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

74.64
+1.992.74%
Post-market: 74.50-0.1400-0.19%19:50 EDT
Volume:4.96M
Turnover:367.84M
Market Cap:43.82B
PE:10.64
High:74.81
Open:72.75
Low:72.67
Close:72.65
52wk High:83.00
52wk Low:64.89
Shares:587.10M
Float Shares:581.10M
Volume Ratio:1.36
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.02
EPS(LYR):6.98
ROE:15.53%
ROA:8.42%
PB:4.16
PE(LYR):10.69

Loading ...

Edwards Lifesciences Corp. Stock Climbs 2.7%, Outperforms Peers

Dow Jones
·
Yesterday

Edwards Lifesciences added to ‘Tactical Outperform’ list at Evercore ISI

TIPRANKS
·
Oct 17

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $84 From $85, Maintains Market Perform Rating

MT Newswires Live
·
Oct 14

Edwards Lifesciences Corp : Leerink Partners Cuts Target Price to $84 From $85

THOMSON REUTERS
·
Oct 14

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Oct 14

Press Release: Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Dow Jones
·
Oct 10

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 09

Abbott Laboratories Still Offers Attractive Valuation, UBS Says

MT Newswires Live
·
Oct 09

Edwards Lifesciences' Long-Term Plan Raises Concerns Amid 'Structural' Risks, Oppenheimer Says

MT Newswires Live
·
Oct 08

Edwards Lifesciences : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Oct 08

Oppenheimer Downgrades Edwards Lifesciences to Market Perform From Outperform

MT Newswires Live
·
Oct 08

UBS Sticks to Its Hold Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Oct 08

Edwards Lifesciences Raised to Outperform From In-Line by Evercore ISI Group

Dow Jones
·
Oct 07

Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80

MT Newswires Live
·
Oct 07

Edwards Lifesciences upgraded to Outperform from In Line at Evercore ISI

TIPRANKS
·
Oct 07

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 02

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $94 From $101, Maintains Buy Rating

MT Newswires Live
·
Oct 01

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 30

This overlooked group of stocks might be your portfolio's missing piece

Dow Jones
·
Sep 27

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 27